tiprankstipranks
Trending News
More News >
OncoCyte Corp (OCX)
NASDAQ:OCX
US Market

OncoCyte (OCX) Technical Analysis

Compare
425 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
4Neutral
11Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
OncoCyte Corp’s (OCX) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting OncoCyte Corp is a Buy.
OncoCyte Corp’s (OCX) 20-Day exponential moving average is 2.91, while OncoCyte Corp’s (OCX) share price is $2.79, making it a Sell.
OncoCyte Corp’s (OCX) 50-Day exponential moving average is 2.94, while OncoCyte Corp’s (OCX) share price is $2.79, making it a Sell.

OncoCyte (OCX) Pivot Points

May 16, 2025, 07:29 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.41
2.50
2.55
2.65
2.70
2.79
2.84
Fibonacci
2.50
2.56
2.59
2.65
2.70
2.73
2.79
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoCyte (OCX) Moving Averages

May 16, 2025, 07:29 AM
Period
Simple
Exponential
MA5
2.77Buy
2.77Buy
MA10
2.83Sell
2.83Sell
MA20
2.96Sell
2.91Sell
MA50
3.15Sell
2.94Sell
MA100
2.74Buy
2.88Sell
MA200
2.83Sell
2.90Sell
OncoCyte Corp’s (OCX) 10-Day exponential moving average is 2.83, while OncoCyte Corp’s (OCX) share price is $2.79, making it a Sell.
OncoCyte Corp’s (OCX) 100-Day exponential moving average is 2.88, while OncoCyte Corp’s (OCX) share price is $2.79, making it a Sell.
OncoCyte Corp’s (OCX) stock price is $2.79 and OncoCyte Corp’s (OCX) 50-day simple moving average is 3.15, creating a Sell signal.
OncoCyte Corp’s (OCX) stock price is $2.79 and OncoCyte Corp’s (OCX) 100-day simple moving average is 2.74, creating a Buy signal.
OncoCyte Corp’s (OCX) stock price is $2.79 and OncoCyte Corp’s (OCX) 200-day simple moving average is 2.83, creating a Sell signal.

OncoCyte (OCX) Technical Indicators

May 16, 2025, 07:29 AM
Name
Value
Implied Action
RSI (14)
44.07
Neutral
STOCH (9,6)
20.00
Neutral
STOCHRSI (14)
16.67
Buy
MACD (12,26)
-0.08
Buy
ADX (14)
12.53
Buy
Williams %R
-74.71
Buy
CCI (14)
-90.68
Neutral
ATR (14)
0.25
-
Ultimate Oscillator
43.74
Neutral
ROC
-18.90
Sell
OncoCyte Corp’s (OCX) Relative Strength Index (RSI) is 44.07, creating a Neutral signal.
OncoCyte Corp’s (OCX) Trend Strength Indicator (ADX) is 12.53, creating a Buy signal.
OncoCyte Corp’s (OCX) Commodity Channel Index (CCI) is -90.68, creating a Neutral signal.
OncoCyte Corp’s (OCX) Price Rate of Change (ROC) is -18.90, creating a Sell signal.

FAQ

Is OCX a Buy, Hold, or Sell?
Based on OCX’s technical indicators, OCX is a Sell.
    What is OCX’s RSI (14)?
    OCX’s RSI (14) is 44.07, which suggests OCX is a Neutral.
      What is OCX’s MACD?
      OCX’s MACD is -0.08, which suggests OCX is a Buy.
        What is OCX’s 5-day moving average?
        OCX’s 5-day moving average is 2.77, which suggests OCX is a Buy.
          What is OCX’s 20-day moving average?
          OCX 20-day moving average is 2.96, which suggests OCX is a Sell.
            What is OCX’s 50-day moving average?
            OCX’s 50-day moving average is 3.15, which suggests OCX is a Sell.
              What is OCX’s 200-day moving average?
              OCX’s 200-day moving average is 2.83, which suggests OCX is a Sell.
                What is OCX’s Williams % R (14)?
                OCX’s Williams % R (14) is -74.71, which suggests OCX is a Buy.
                  What is OCX’s CCI (14)?
                  OCX’s CCI (14) is -90.68, which suggests OCX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis